期刊文献+

Inhibitiory effects of procainamide on rabbit platelet aggregation and thromboxane B_2 production in vitro 被引量:2

Inhibitiory effects of procainamide on rabbit platelet aggregation and thromboxane B 2 production in vitro
原文传递
导出
摘要 目的:研究普鲁卡因胺(PA)对凝血酶诱导血小板聚集和血栓素B2(TXB2)产生的影响.方法:用比浊法和放射免疫分析法.结果:普鲁卡因胺85,34,136和544μmol·L-1有明显抑制作用.抑制率分别为45%±37%,48%±32%,88%±23%,92%±15%和53%±24%,65%±26%,90%±6%,95%±6%.PA的浓度与血小板聚集和TXB2产生的抑制效力之间,以及血小板聚集抑制率和TXB2产生的抑制率之间均存在着正相关关系,三者的线性方程和主要参数为:^Y=02075X-49157,r=09985;^Y=09546X-346724,r=09921;^Y=08202X+197062,r=09921.结论:普鲁卡因胺抑制凝血酶诱导血小板聚集和TXB2产生. AIM: To study the influences of procainamide (PA) on thrombin induced rabbit platelet aggregation and thromboxane B 2 (TXB 2) production in vitro . METHODS: Turbidimetry and radioimmunoassay were used. RESULTS: PA 8 5, 34, 136, and 544 μmol·L -1 inhibited thrombin induced platelet aggre ̄ga ̄tion and TXB 2 production, and the inhibitory rates were 45 %±37 %, 48 %±32 %, 88 %±23 %, 92 %±15 % and 53 %±24 %, 65 %±26 %, 90 % ±6 %, 95 %±6 %, respectively. There was positive correlation between PA concentration and efficiency of inhibition of platelet aggregation and TXB 2 production, and also between the inhibition % of platelet aggregation and that of production of TXB 2. The three linear equations and main parameters were =0 2075X-4 9157, r =0 9985; =0 9546X-34 6724, r =0 9921; =0 8202X+19 7062, r =0 9921. CONCLUSION: PA inhibited thrombin induced platelet aggregation and TXB 2 production in rabbits.
出处 《中国药理学报》 CSCD 1998年第2期164-166,共3页 Acta Pharmacologica Sinica
关键词 普鲁卡因胺 血小板聚集 血栓素B2 procainamide platelet aggregation thromboxane B 2 thrombin
  • 相关文献

参考文献10

  • 1Pang J X,J Med Coll PLA,1996年,11卷,241页
  • 2Pang J X,中国药理学报,1996年,17卷,500页
  • 3Pang J X,中国药理学报,1996年,17卷,87页
  • 4Yang Y S,中国药理学报,1994年,15卷,339页
  • 5单春文,中国药理学报,1993年,14卷,127页
  • 6单春文,中国药理学报,1990年,11卷,527页
  • 7单春文,中国药理学报,1988年,9卷,338页
  • 8Ruan C G,Blood platelet-foundation and clinic,1987年,38页
  • 9Sun R Y,Quantitative pharmacology,1987年,404页
  • 10单春文,中国药理学报,1986年,7卷,63页

同被引文献15

  • 1杨树森,赵进军,王岚峰,孙宝贵,周玉杰,王若丹,黄永麟,傅世英,林继红,张英华,师清芝,田景春,马丽英.鱼油制剂在动脉腔内成形术中改善血小板膜流动性及粘附率的实验研究[J].中国循环杂志,1995,10(10):614-616. 被引量:2
  • 2周远鹏,刘文化,邵国贤.益母草碱、丁香酰胍醇及丁香酸氨基醇酯类化合物抗血小板聚集活性及其与结构的关系[J].中国药学杂志,1996,31(5):271-274. 被引量:18
  • 3许崇华译.血小板凝聚抑制剂氯吡格雷硫酸氢盐[J].药学进展,1996,20(4):233-233.
  • 4高永洁 张焕景 等.天保宁对肺心病人血小板聚集功能的影响[J].中国医院药学杂志,1999,19(1):41-41.
  • 5Mckee SA,Sane DC,Deliargyris EN.Aspirin resistance in cardiovascular disease:A review of prevalence,mechanisms,and clinical significance[J].Thromb Haemost,2002,88(5):711.
  • 6阮长耿.抗血小板药物研究进展,http://www.zjicu.com.2005,5,1.网络文章.
  • 7Savi P,Pereillo JM,Uzabiaga MF,et al.Identification and biological activity of the active metabolite of clopidogrel[J].Thromb Haemost,2000,84(5):891.
  • 8EPIC Investigators.Use a monoclonal antibody directed against the platelet glycoprotein receptor in high-risk coronaty angioplasty.N Engl J Med,1994,330:956.
  • 9Charo IF,Scarborough RM,duMee CP,et al.Pharamcodynamics of the GP GPⅡb/Ⅲa antagonist integrelin:phase clinical studies in nomal healthy volunteers[abstract].Circulation,1992,86[suppl I]:259-260.
  • 10张衡.抗血小板聚集药沙替格雷[J].药学进展,1997,21(3):181-182. 被引量:2

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部